Tyrosine kinase receptor inhibitor as a molecularly targeted therapy for solid tumors
Advances in solid tumor treatment have been enormous in the past decade, especially molecularly targeted therapy, for which aberrant molecules or biological pathways relating to tumor growth and development have been targeted specifically. Molecularly targeted therapy agents show activity against sp...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Prince of Songkla University
2006-01-01
|
Series: | Journal of Health Science and Medical Research (JHSMR) |
Subjects: | |
Online Access: | https://www.jhsmr.org/index.php/jhsmr/article/view/557 |